Human TET2 Bridges Cancer and Immunity
Overview
Authors
Affiliations
TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.
Gao Q, Shen K, Xiao M Clin Epigenetics. 2024; 16(1):155.
PMID: 39521964 PMC: 11550532. DOI: 10.1186/s13148-024-01771-2.
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R, Fu D, Dong L, Zhang M, Shi Q, Shi Z Signal Transduct Target Ther. 2023; 8(1):145.
PMID: 37032379 PMC: 10083170. DOI: 10.1038/s41392-023-01358-y.
Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance.
Rudich A, Garzon R, Dorrance A Int J Mol Sci. 2022; 23(20).
PMID: 36293127 PMC: 9603161. DOI: 10.3390/ijms232012271.
Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis.
Joshi K, Zhang L, Breslin S J P, Kini A, Zhang J J Exp Clin Cancer Res. 2022; 41(1):294.
PMID: 36203205 PMC: 9540719. DOI: 10.1186/s13046-022-02496-x.
TET2 Inhibits Gene Expression in Breast Cancer Cells through Histone Deacetylation.
Shen Y, Liu L, Wang M, Xu B, Lyu R, Shi Y Cancers (Basel). 2021; 13(9).
PMID: 34064441 PMC: 8125390. DOI: 10.3390/cancers13092207.